All In Biotech

Drug Trial Radar · NCT04521114

Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis

A Phase II, Multi-center, Two-Part, Three-Arm, Dose-Ranging Study of the Safety and Efficacy of Leronlimab (PRO 140) in Adult Patients With Nonalcoholic Steatohepatitis (NASH)

Last checked: Nov 19, 2026Latest source record: Mar 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

87

Actual

Start

Dec 1, 2020

Primary completion

Dec 29, 2021

Study completion Dec 29, 2021

Sponsor

Lead sponsor
CytoDyn, Inc.Industry
Sponsor type
Industry
First posted
Aug 20, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase II study of of Leronlimab (PRO 140)-Humanized monoclonal antibody to CCR5 in patients with Nonalcoholic Steatohepatitis (NASH).

Conditions

  • Nonalcoholic Steatohepatitis (NASH)

Interventions

  • PlaceboDrug

    Placebo will be administered subcutaneously every week for 13 weeks.

  • leronlimab 700 mgDrug

    700 mg leronlimab will be administered subcutaneously every week for 13 weeks.

  • leronlimab 350 mgDrug

    350 mg leronlimab will be administered subcutaneously every week for 13 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MRI-PDFF Change From Baseline to Week 14Time frame: Change from baseline (day one, first day of treatment) to EOT (day 92, 13 weeks of treatment)

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Southern California Research Center

    Coronado, California

  • Meridien Research

    Maitland, Florida

  • Floridian Clinical Research

    Miami Lakes, Florida

  • Sensible Healthcare, LLC

    Ocoee, Florida

  • Center for Advanced Research & Education

    Gainesville, Georgia

  • Care United Research LLC

    Forney, Texas

  • American Research Corporation

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.